Context Therapeutics (6K9) Cash flow

1 Followers

Context Therapeutics Cash Flow

DE:6K9's free cash flow for Q2 2026 was $-7.04M. For the 2026 fiscal year, DE:6K9's free cash flow was decreased by $2.89M and operating cash flow was $-7.02M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -26.39M	$ -14.56M	$ -21.05M	$ -13.55M	$ -8.80M
Investing Cash Flow	$ -2.03M	$ -14.76M	$ 0.00	$ -536.84K	$ -250.00K
Financing Cash Flow	$ -15.27K	$ 109.29M	$ 0.00	$ -102.07K	$ 58.39M
End Cash Position	$ 66.00M	$ 94.43M	$ 14.45M	$ 35.50M	$ 49.69M
Free Cash Flow	$ -26.42M	$ -29.31M	$ -21.05M	$ -14.09M	$ -9.05M

Currency in USD